EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Extracellular Vesicles from Synovial Fibroblast‐Primed MSCs for Osteoarthritis Treatment

Seo Jeong Kim, Ji Seob Kim, Min Hee Moon, Jae-Hyeok Jang, In Sun Hwang, Byung-Hyun Cha iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Seo Jeong Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Systems Science, College of Biomedical Science, Kangwon National University, Chuncheon-si, Republic of Korea. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Osteoarthritis, Fibroblasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea government, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells (MSCs) migrate to injured tissues through a homing effect and promote tissue regeneration by secreting paracrine factors and extracellular vesicles (EVs) and interacting with resident cells. MSC‐derived EVs have emerged as promising therapeutic candidates for osteoarthritis (OA) because they carry bioactive molecules, are easily delivered, and exhibit low immunogenicity. In this study, we generated MSCs with altered cell fate by transferring the microenvironment of SW982 human synovial fibroblast‐like cells through direct MSC–synovial fibroblast (SF) interaction and evaluated EVs derived from these cells (miSF‐MSC‐EVs) as a therapeutic strategy for OA. MSCs and SFs were stained with nuclear dyes, co‐cultured for 48 h, and double‐positive cells were isolated by fluorescence‐activated cell sorting. Proteomic and next‐generation sequencing analyses revealed enrichment of miRNAs associated with cell migration, adhesion, and transforming growth factor‐β, Wnt, and PI3K signaling pathways in miSF‐MSC‐EVs. Compared with conventional MSC‐EVs, miSF‐MSC‐EVs enhanced cell proliferation, improved regenerative responses, reduced inflammatory marker expression, and increased anti‐inflammatory marker expression in vitro. Furthermore, miSF‐MSC‐EVs promoted cartilage repair in a mouse OA model, highlighting their potential as a regenerative therapeutic platform for OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMesenchymal Stem CellsOsteoarthritisFibroblastsSynovial MembraneHumansAnimalsMiceCell ProliferationCell MovementMicroRNAs

Stichwörter der Autor:innen

cell to cell interactionextracellular vesicles (EVs)mesenchymal stem cells (MSCs)osteoarthritis (OA)synovial fibroblasts

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Biomedical Systems Science, College of Biomedical Science, Kangwon National University, Chuncheon-si, Republic of Korea.

ORCID-Profile: Byung-Hyun Cha

Förderung

  • National Research Foundation of Korea
  • Korea government
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Kim, S. J., Kim, J. S., Moon, M. H., Jang, J. H., Hwang, I. S., & Cha, B. H. (2026). Therapeutic Extracellular Vesicles from Synovial Fibroblast‐Primed MSCs for Osteoarthritis Treatment. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71406

Vancouver

Kim SJ, Kim JS, Moon MH, Jang JH, Hwang IS, Cha BH. Therapeutic Extracellular Vesicles from Synovial Fibroblast‐Primed MSCs for Osteoarthritis Treatment. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71406

BibTeX
@article{Kim2026,
  author = {Kim, Seo Jeong and Kim, Ji Seob and Moon, Min Hee and Jang, Jae-Hyeok and Hwang, In Sun and Cha, Byung-Hyun},
  title = {Therapeutic Extracellular Vesicles from Synovial Fibroblast‐Primed MSCs for Osteoarthritis Treatment},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71406}
}
Kostenlos starten →